For adults with type 2 diabetes and chronic kidney disease, Ozempic is used to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death
Although clinical research is in its early stages, emerging data, anecdotal reports, and pharmacoepidemiologic findings suggest these agents may be effective for alcohol, opioid, stimulant, and tobacco use disorders
What to Tell Your Healthcare Provider If youre experiencing persistent lumps, rash, or redness after a GLP-1 injection or if theyre simply becoming bothersome contact your healthcare provider
So, with a dose specifically tailored to the patient, the weight comes off
First, the influence on gastrointestinal motility among GLP-1 receptor agonists may differ, and the results may not apply to other GLP-1 RAs or DPP-4i